What CVS Health Holders Bought Into

CVS Health’s latest launch of its Health100 AI platform and rapid build out of GLP 1 programs gave investors something very concrete to react to, as the business sharpened its focus on higher margin healthcare services and technology. For CVS Health shareholders, the return from the start of the year was 20.2%, including dividends. If someone had been deciding whether to buy on 1 January 2026, what exactly did they need to believe before any of this news hit the tape? On Simply Wall St, a...